Intravenous Immunoglobulin Treatment of Neurological Disease
JNNP 60:359-361, Otten,A.,et al, 1996
Cost-Effectiveness Analysis:What Is It and How Will It Influence Neurology
Ann Neurol 39:818-823, Holloway,R.G., 1996
Thalamic Haemorrhage
Brain 119:1873-1886, Chung,C-S.,et al, 1996
Idiopathic Acute Transverse Myelitis:MR Imaging Findings
Radiology 201:661-669, Tartaglino,L.M.,et al, 1996
Distal WEakness in Dystrophin-Deficient Muscular Dystrophy
Muscle & Nerve 19:1608-1610996., Felice,K.J., 1996
Inclusion Body Myositis:Clinical and Pathological Boundaries
Ann Neurol 40:581-586, Amato,A.A.,et al, 1996
Charcot-Marie-Tooth Disease and Related Inherited Neuropathies
Medicine 75:233-250, Murakami,T.,et al, 1996
Idiopathic Dysautonomia Treated with Intravenous Gammaglobulin
Lancet 347:28-29, Heafield,M.T.E.,et al, 1996
Silent Brain Infarction in Nonrheumatic Atrial Fibrillation
EAFT Study Group, Neurol 46:159-1651996., , 1996
Reversible Encephalopathy with Cerebral Vasospasm in a Guillain-Barre Syndrome Patient Treated with Intravenous Immunoglobulin
Neurol 46:250-251, Voltz,R.,et al, 1996
Liver Function Disturbances in Guillain-Barre Syndrome:A Prospective Longitudinal Study in 100 Patients
Neurol 46:96-100, Oomes,P.G.,et al, 1996
Pilot Trial of Immunoglobulin Versus Plasma Exchange in Patients with Guillain-Barre Syndrome
Neurol 46:100-103, Bril,V.,et al, 1996
Childhood Leukemia:Central Nervous System Abnormalities During and After Treatment
AJNR 17:295-310, Chen,C-Y.,et al, 1996
Brain Edema after Carotid Surgery
Neurol 46:175-181, Breen, J.C.,et al, 1996
Diphtheritic Neuropathy
Muscle & Nerve 18:1460-1463995., Greange,A.,et al, 1995
Canavan Disease:From Spongy Degeneration to Molecular Analysis
J Pediatr 127:511-517, Matalon,R.,et al, 1995
Comparison of Triple Dose vs Std Dose Gadolinium-DTPA for Detect of MRI Enhanc Lesions in Pts with Primary Progr MS
JNNP 59:540-544, Filippi,M.,et al, 1995
Campylobacter Jejuni Infection and Guillain-Barre Syndrome
NEJM 333:1374-1379, 14151995., Rees,J.H.,et al, 1995
Neurological Correlated of Fetal Cocaine Exposure:Transient Hypertonia of Infancy and Early Childhood
Pediatrics 96:1070-1077, Chiriboga,C.A.,et al, 1995
Neurological and Functional Outcome in Patients with Supratentorial Hemorrhages:A Prospective Study
Stroke 26:2249-2253, Lampl,Y.,et al, 1995
Quality of Life After Stroke:Impact of Stroke Type and Lesion Location
Stroke 26:402-408, deHaan,R.J.,et al, 1995
Low-Dose (7. 5mg) Oral Methotrexate Reduces the Rate of Progression in Chronic Progressive Multiple Sclerosis
Ann Nuerol 37:30-40, 51995., Goodkin,D.E.,et al, 1995
Neurologic Aspects of Inflammatory Bowel Disease
Neurol 45:416-421, Lossos,A.,et al, 1995
Stroke Patterns in Unilateral Atherothrombotic Occlusion of the Internal Carotid Artery
Stroke 26:422-425, Mounier-Vehier,F.,et al, 1995
Clinicopath Conf
Qunidine-Induced Thrombocytopenia, Cerebral Hemorrhage, Case 15-1995, NEJM 332:1363-137095., , 1995
Variability of Vascular Territory in Stroke:Pitfalls and Failure of Stroke Pattern Interpretation
Stroke 26:942-945, Lang,E.W.,et al, 1995
Impact of Thalamic Hematoma on Six-Month Mortality and Motor and Cognitive Functional Outcome
Stroke 26:620-626, Mori,S.,et al, 1995
Thalamic Hemorrhage:A Prospective Study of 100 Patients
Stroke 26:964-970, Kumral,E.,et al, 1995
Diminished Nocturnal Blood Pressure Decline and Lesion Site in Cerebrovascular Disease
Stroke 26:829-833, Yamamoto,Y.,et al, 1995
Interferon Beta-1b in the Trtm of MS:Outcome of the Randomized Controlled Trial
IFNB Study Gr, Neurol 45:1277-12851995., , 1995
Effect of Interferon-B on Blood-Brain Barrier Disrupt Demonst by Contrast MRI in Relapsing-Remitting MS
Ann Neurol 37:611-619, Stone,L.A.,et al, 1995
Copolymer 1 Reduces Relapse Rate & Improves Disability in Relapsing-Remitting MS:Multictr Trial
Neurol 45:1268-1276, Johnson,K.P.,et al, 1995
Hyperosmolar Coma Due to Lithium-Induced Diabetes Insipidus
Lancet 346:413-417, MacGregor,D., 1995
Cranial Nerve Enhancement in the Guillain-Barre Syndrome
AJNR 16:923-925, Fulbright,R.K.,et al, 1995
Lyme Neuroborreliosis
Ann Neurol 37:691-702, Garcia-Monco,J.C.&Benach,J.L., 1995
Clinical Variability in Adult-Onset Acid Maltase Deficiency:Report of Affected Sibs and Review of Literature
Medicine 74:131-135, Felice,K.J.,et al, 1995
Risk Factors for Impaired Outcome after Spontaneous Intracerebral Hemorrhage
Arch Neurol 52:1193-1200, Juvela,S., 1995
Polyarteritis Nodosa-Induced Quadriplegia
Ann Int MEd 122:731-732, Smith,D.L.,et al, 1995
MRI in Intraspinal Tuberculosis
Neuroradiology 36:39-43, Gupta,r.K.,et al, 1994
Myotonic Dystrophy
In Myology, Engel & Franzini-Armstrong, McGraw-Hill, Inc, New York V2, Ch 43, P1192, Harper,P.S.&Rudel,R., 1994
Intensive Care of Acute Guillain-Barre Syndrome
Can J Neurol Sci 21:S23-S27, Ropper.,A.H., 1994
Pain in the Guillain-Barre Syndrome: A Clinical Review
Pain 59:159-164, Pentland,B. &Donald,S.M., 1994
Prospective Evaluation of Cerebral Angiography and Computed Tomography in Cerebral Haematoma
JNNP 57:1180-1186, Halpin,S.F.S.,et al, 1994
Autonomic Involvement in Guillain-Barre Syndrome:A Review
Muscle & Nerve 17:1145-1155994., Zochodne,D.W., 1994
Monomelic Amyotrophy
Muscle & Nerve 17:1129-1134994., Donofrio,P.D., 1994
Electroencephalography
JNNP 57:1308-1319, Binnie,C.D.&Prior,P.F., 1994
Causes and Mechanisms of Territorial and Nonterritorial Cerebellar Infarcts in 115 Consecutive Patients
Stroke 25:105-112, Amarenco,P.,et al, 1994
The Clinical Correlates of High-Titer IgG Anti-GM1 Antibodies
Ann Neurol 35:234-237, Kornberg,A.J.,et al, 1994
Plasma Exchange and Intravenous Immunoglobulin Treatment of Neuromuscular Disease
Ann Neurol 35:260-268, Thornton,C.A.&Griggs,R.C., 1994
Neurologic Manifestations of Cocaine Exposure in Childhood
Pediatrics 93:557-560, Mott,S.H.,et al, 1994